Chart calendar Can-Fite BioPharma Ltd.

42aed1520b483e6f21c5338b80db.OyEpY16UPFURS-L9Ehr_icQMAOQ5zYOVvTkCLtkR26k.T34QMzvYSixYJJDLI1-m27d7eaZXlLHZ1FY0b5NOmP5zQ2FXKvFMEiYCtw~2a3cb130a4a8254b4388d39b3378055a

Upcoming events on Can-Fite BioPharma Ltd.

2025-08-27 Q2 2025 Earnings Release (Projected)
2026-03-25 Q4 2025 Earnings Release (Projected)
2026-08-26 Q2 2026 Earnings Release (Projected)

Past events on Can-Fite BioPharma Ltd.

2025-06-23 08:00 am Annual General Meeting
2025-06-15 BIO International Convention
2025-04-14 08:00 am Q4 2024 Earnings Release
2025-02-25 04:15 pm Business Update Call
2025-02-10 03:45 pm BIO CEO & Investor Conference
2025-01-22 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
2024-10-29 04:15 pm Analyst Meeting - Redchip
2024-08-29 08:15 am Q2 2024 Earnings Release
2024-08-08 04:15 pm Analyst Meeting - Redchip
2024-06-26 08:00 am Annual General Meeting
2024-06-06 04:15 pm Business Update Call
2024-06-02 Bio International Convention
2024-05-01 06:00 pm Planet MicroCap Showcase
2024-04-09 04:30 pm LD Micro Invitational Conference
2024-03-28 07:00 am Q4 2023 Earnings Release
2024-03-17 BioEurope Spring Conference
2024-01-25 09:00 am Sequire Investor Summit
2023-11-30 07:00 am Q3 2023 Earnings Release
2023-10-10 Bio Japan Conference
2023-09-26 AACR Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
0,81
1,41
-42.7%
0,74
0,80
-7.13%
0,67
0,50
34.8%

0,00


10,8


43,3

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-10,1
-13,9
27.17%
-8,20
-8,30
1.27%
-8,13
-8,75
7.11%

-9,07


-0,63


25,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,2
-9,20
-10.58%
-7,63
-7,90
3.37%
-7,88
-8,65
8.93%

-9,07


-0,63


25,3

Net income
Million USD
Released
Forecast
Spread
-10,2
-14,2
28.14%
-7,63
-7,90
3.37%
-7,88
-8,65
8.93%

-9,07


-0,63


24,0

EPS
ILS
Released
Forecast
Spread
-0,04
-0,05
30.56%
-0,04
-0,04
0.76%
0,00
0,00
-

0,00


0,00


0,00

Announcement Date30/03/2328/03/2414/04/25-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
0,20
0,20
-2%
0,20
0,20
-2%
0,16
0,20
-22.5%

0,15


0,15


0,15


0,15


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-1,78
-2,90
38.48%
-1,87
-1,80
-3.61%
-1,83
-1,90
3.47%

-2,12


-2,21


-2,20


-2,34


-2,09


-2,18


-2,36


-2,45

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,67
-2,70
38.15%
-1,76
-1,70
-3.65%
-1,65
-1,90
13.05%

-2,12


-2,21


-2,20


-2,29


-2,09


-2,18


-2,36


-2,45

Net income
Million USD
Released
Forecast
Spread
-1,67
-2,80
40.36%
-1,76
-1,70
-3.65%
-1,65
-1,90
13.05%

-2,12


-2,21


-2,20


-2,29


-2,09


-2,18


-2,36


-2,45

EPS
ILS
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-0,04
0,00
-

0,00


0,00


0,00


0,00













Announcement Date31/08/2330/11/2328/03/24--------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CANF Stock
  4. Calendar Can-Fite BioPharma Ltd.